As per the research report, the Atherectomy Devices Market size in the Asia Pacific was worth USD 82.47 million in 2021. It is estimated to be growing at a CAGR of 7.1%, to reach USD 116.21 million by 2026.
Growing demand for minimally invasive surgical procedures, increasing research and development activities in this region are primarily accelerating market growth. The rising amount spent on healthcare and standard increase of peripheral artery diseases (PAD) is likely to fuel the Asia Pacific atherectomy devices market during the analysis period.
Additionally, rising knowledge levels among the patients regarding the diagnosis of peripheral coronary diseases and growing medical reimbursement policies for the vascular treatment processes are expected to lavish the growth rate of the market. Also, clinical advantages provided and the continuous technological advancements in the atherectomy devices are further estimated to support the market growth in this region.
Notably, lack of awareness regarding the associated with among people and high costs associated with the treatment options using atherectomy devices are majorly impeding the market growth. Strict regulatory frameworks for the approval of the atherectomy devices and alternative therapies available in the market are expected to restrict the market growth in the Asia Pacific to some extent.
This research report on the Asia-Pacific Atherectomy Devices Market has been segmented and sub-segmented into the following categories:
By Type:
By Application:
By End User:
By Country:
Regionally, the Asia Pacific Atherectomy Devices Market will exhibit the highest growth rate in the forecast period because of the developing economy and increased healthcare costs.
The Chinese Atherectomy Devices Market dominates the APAC region and is expected to continue its dominance in the forthcoming years. The market size value of China is expected to worth USD 54.3 Million by 2024 with a CAGR of 5.9% from 2020 to 2025 owing to the developing economy and growing healthcare expenditure in this region.
The Indian Atherectomy Devices Market is estimated to have a bright future during the forecast period and is predicted to showcase a CAGR value of 7.1% over the forecast period. Factors such as socioeconomic changes like smoking, unhealthy diet and consumption of liquor, and the aging population increase aimed diseases, which will demand market growth.
The Japanese Atherectomy Devices Market size value is expected to have a CAGR value of 6.8% during the forecast period.
Key market participants dominating the APAC Atherectomy Devices Market profiled in the report are Bayer HealthCare, C. R. Bard, Inc., Cardinal Health (Cordis), Avinger, Inc., Boston Scientific Corporation, Straub Medical AG, St. Jude Medical, Cardiovascular Systems, Inc., and Spectranetics.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Directional
5.1.3 Rotational
5.1.4 Orbital
5.1.5 Lateral
5.1.5 Y-o-Y Growth Analysis, By Type
5.1.6 Market Attractiveness Analysis, By Type
5.1.7 Market Share Analysis, By Type
5.2 Application
5.2.1 Introduction
5.2.2 Peripheral
5.2.3 Cardiovascular
5.2.4 Neurovascular
5.2.5 Y-o-Y Growth Analysis, By Application
5.2.6 Market Attractiveness Analysis, By Application
5.2.7 Market Share Analysis, By Application
5.3 End User
5.3.1 Introduction
5.3.2 Hospitals
5.3.3 Surgical Centers
5.3.4 Research Laboratories
5.3.5 Academic Institutes
5.3.6 Y-o-Y Growth Analysis, By End User
5.3.7 Market Attractiveness Analysis, By End User
5.3.8 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By Application
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By Application
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By Application
6.1.5.4 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Bayer HealthCare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 C. R. Bard, Inc.
8.3 Cardinal Health (Cordis)
8.4 Boston Scientific Corporation
8.5 Straub Medical AG
8.6 St. Jude Medical
8.7 Spectranetics
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
